Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
An. bras. dermatol ; 91(5,supl.1): 17-19, Sept.-Oct. 2016. graf
Artículo en Inglés | LILACS | ID: biblio-837935

RESUMEN

Abstract Bromoderma is a cutaneous eruption caused by the absorption of bromide. Clinical manifestations include acneiform and vegetative lesions. We report the case of an infant with bromoderma caused by the use of syrup for abdominal colic containing calcium bromide. The lesions regressed after discontinuation of the drug.


Asunto(s)
Humanos , Masculino , Lactante , Bromuros/efectos adversos , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/patología , Compuestos de Calcio/efectos adversos , Piel/patología , Cólico/tratamiento farmacológico , Erupciones Acneiformes/inducido químicamente , Erupciones Acneiformes/patología
2.
An. bras. dermatol ; 86(2): 336-338, mar.-abr. 2011. ilus
Artículo en Portugués | LILACS | ID: lil-587671

RESUMEN

Esclerose múltipla é uma doença inflamatória desmielinizante, com presumida origem autoimune, que afeta o sistema nervoso central. A principal modalidade terapêutica é baseada no uso de imunomoduladores, como o interferon beta, que são geralmente bem tolerados. As manifestações cutâneas secundárias ao interferon beta-1b são representadas, na maioria das vezes, por reações no local de sua aplicação subcutânea. Descrevemos o caso de uma paciente do sexo feminino que desenvolveu um quadro de erupção acneiforme pelo interferon beta-1b.


Multiple sclerosis is an inflammatory demyelinating disease of presumed autoimmune origin that affects the central nervous system. The main form of therapy is based on the use of immunomodulators such as interferon beta, which are usually well tolerated. Skin manifestations resulting from treatment with interferon beta-1b consist principally of reactions at the site of subcutaneous application of the drug. The present case report describes a female patient who developed an acneiform eruption resulting from treatment with interferon beta-1b.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Erupciones Acneiformes/inducido químicamente , Adyuvantes Inmunológicos/efectos adversos , Erupciones por Medicamentos , Interferón beta/efectos adversos , Enfermedad Aguda , Erupciones Acneiformes/diagnóstico , Adyuvantes Inmunológicos/uso terapéutico , Erupciones por Medicamentos/diagnóstico , Interferón beta/uso terapéutico , Esclerosis Múltiple/tratamiento farmacológico
3.
Yonsei Medical Journal ; : 851-852, 2008.
Artículo en Inglés | WPRIM | ID: wpr-153690

RESUMEN

Epidermal growth factor has an important role in the regulation of proliferation and differentiation in epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of cancer cells. Cetuximab is a chimeric monoclonal antibody selective for the epidermal growth factor receptor that induces a broad range of cellular responses that enhance tumor sensitivity to radiotherapy and chemotherapeutic agents. However, it can cause adverse events in the patient including acneiform eruption, asthenia, abdominal pain and nausea/vomiting. We report a case of severe acneiform eruption induced by cetuximab in a 56-year-old man with colorectal cancer and liver metastases.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Erupciones Acneiformes/inducido químicamente , Anticuerpos Monoclonales/efectos adversos , Antineoplásicos/efectos adversos , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico
4.
JPAD-Journal of Pakistan Association of Dermatologists. 2000; 10 (3): 5-7
en Inglés | IMEMR | ID: emr-54271

RESUMEN

Adolescent and post adolescent females presented to Dermatology Out patients with white comedones and inflamed papules, situated mainly on cheeks and forehead. Most of these patients related the onset of these lesions after continuous use of a beauty cream to improve complexion. Twenty four patients presenting to the Outpatients Department of Dermatology at Abbassi Shaheed Hospital and Burhani Community Hospital, were collected. Subjects were questioned about their acneiform eruption. Each patient was examined and beauty products and 17 betamethasone valerate cream were shown to them for correct identification. All patients related the lesions after continuous application of the beauty cream obtained after mixing 5gm tube of betamethasone valerate cream with one tube each of two famous beauty products. The average daily application lasted for about three months. The predominant lesions were white comedones and inflamed papules [100%]; macular erythema and telangiectasia were seen in [16%.] The cheeks and forehead were universally involved in all patients and the chin was involved in four [16%]. The majority belonged to middle and low-income families. Conclusions: Since time immemorial, females have used beauty products to improve their complexion. The recent amateur addition of 17- betamethasone valerate to commercial beauty creams has led to more acneiform eruptions


Asunto(s)
Humanos , Femenino , Erupciones Acneiformes/inducido químicamente , Administración Tópica/efectos adversos , Valerato de Betametasona/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA